A prospective multicenter study of the Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed or refractory Waldenstrom's macroglobulinemia Meeting Abstract
| Authors: | Treon, S. P.; Tripsas, C. K.; Yang, G.; Cao, Y.; Xu, L.; Hunter, Z.; Cropper, S. J.; Mostyn, P.; Meid, K.; Warren, D.; Patterson, C.; Varma, G.; Laubach, J. P.; Paba-Prada, C. E.; Kunsman, J.; Ghobrial, I. M.; Kanan, S.; Advani, R. H.; Palomba, M. L. |
| Abstract Title: | A prospective multicenter study of the Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed or refractory Waldenstrom's macroglobulinemia |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385000278 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.251.251 |
| Notes: | Meeting Abstract: 251 -- Source: Wos |
